Patents
Patents for C07K 2 - Peptides of undefined number of amino acids; Derivatives thereof (4,723)
07/2001
07/26/2001WO1999064040A8 Novel polyene macrolide compounds and uses
07/19/2001WO2001051011A2 Condensation products of proteins, whereby azelaic acid is used
07/19/2001US20010008934 Stablity; useful in drugs, vaccines, personal care/cosmetics, veterinary drugs/vaccines, foods, feeds, diagnostics, cleaning agents (detergents and decontaminants); catalytic and binding components of biosensors
07/17/2001US6262257 Selective ion- and neutral molecule-binding agents forming supramolecular ensembles, and ion- and neutral molecule-separation agents
07/17/2001US6261804 Selection of proteins using RNA-protein fusions
07/12/2001DE10000493A1 New condensation products of proteins or protein hydrolysates with azelaic acid, are anionic emulsifiers useful in treatment of inflammation and acne and for skin whitening
07/05/2001WO1999064045A9 Novel therapeutic agents for membrane transporters
07/04/2001CN1302376A Corticotropin releasing factor receptor-1 deficient mice
06/2001
06/28/2001WO1999063937A9 Multivalent macrolide antibiotics
06/20/2001EP1107753A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors
06/13/2001EP1105505A2 Compound and method for the prevention and/or the treatment of allergy
06/13/2001EP1105414A2 Synthetic peptides and methods of use for autoimmune disease therapies
06/13/2001EP1105409A2 Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
06/13/2001CN1298881A Solid, stable and concentrated type ortho-silicis acid complex based on bio-absorption, and its prepn. method
06/07/2001WO2001040232A1 Chlorophyll and bacteriochlorophyll esters, and their preparation
06/07/2001WO1999063940A3 INHIBITORS OF H+K+-ATPase
06/07/2001CA2392989A1 Chlorophyll and bacteriochlorophyll esters, their preparation and pharmaceutical compositions comprising them
06/06/2001EP1104457A1 Method for obtaining in vitro recombined polynucleotide sequences, sequence banks and resulting sequences
05/2001
05/31/2001WO1999064041A9 Multibinding agents that modulate nmda receptors
05/30/2001EP1102597A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht 4 receptors
05/29/2001US6238892 Preferential immunoglobulin for the diagnosis and treatment of alzheimer's disease and nervous system disorders
05/29/2001US6238669 Proteins encoded by chicken anemia virus DNA and diagnostic kits and vaccines employing said proteins
05/23/2001EP1100519A1 Multibinding agents that modulate nmda receptors
05/16/2001CN1295668A Methods and compositions for diagnosis of hepatoma
05/16/2001CN1295479A Beta 2-adrenergic receptor agonist
05/15/2001US6232085 Method for determining conditions that stabilize proteins
05/02/2001EP1094826A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors
04/2001
04/25/2001EP0701568B1 New peptide derivatives
04/18/2001EP1092728A2 Biologically digestable complex of orthosilicic acid in a solid, stable and concentrated form and proces for its preparation
04/18/2001EP1091966A1 N-terminal site selective inhibitors of human angiotensin conversion enzyme (ace)
04/12/2001WO2001025794A2 Protein fingerprinting by multisite labelling
04/12/2001CA2388384A1 Protein fingerprint system and related methods
04/11/2001EP1089749A1 Novel therapeutic agents for membrane transporters
04/11/2001EP1021176A4 Cobalt schiff base compounds
04/10/2001US6214293 Microplate thermal shift assay apparatus for ligand development and multi-variable protein chemistry optimization
03/2001
03/28/2001EP1086066A1 Muscarinic receptor antagonists
03/28/2001EP1086065A4 Combinatorial synthesis of multibinding libraries
03/28/2001EP1086065A1 Combinatorial synthesis of multibinding libraries
03/28/2001EP1085895A1 Bradykinin antagonists
03/28/2001EP1085894A1 Beta 3-adrenergic receptor agonists
03/28/2001EP1085893A1 Phosphodiesterase-v modulator drugs and their uses
03/28/2001EP1085891A1 Multibinding inhibitors of topoisomerase
03/28/2001EP1085890A1 Novel sodium channel drugs and uses
03/28/2001EP1085889A2 Novel therapeutic agents that modulate endothelin receptors
03/28/2001EP1085888A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5-ht 3? receptors
03/28/2001EP1085887A2 Novel angiotensin receptor modulators and their uses
03/28/2001EP1085879A2 Multibinding agents that modulate the 5-ht transporter
03/28/2001EP1085870A2 Multivalent agonists, partial agonists and antagonists of the gaba receptors
03/28/2001EP1085868A1 H1-histamine receptor antagonists
03/28/2001EP1085861A1 Inhibitors of nitric oxide synthase
03/28/2001EP1085847A2 Novel therapeutic agents that modulate estrogen receptors
03/28/2001EP1085846A2 Multibinding inhibitors of microsomal triglyceride transferase protein
03/22/2001WO1999063936A8 Novel therapeutic agents that modulate endothelin receptors
03/21/2001EP1083921A1 Novel leukotriene receptor antagonists and their uses
03/21/2001EP1083920A1 Novel antibacterial compounds
03/21/2001EP1083919A1 Novel antiviral compounds
03/21/2001EP1083918A1 Novel therapeutic agents that modulate 5-ht receptors
03/21/2001EP1083917A1 Novel analgesic agents
03/21/2001EP1083893A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d 1? receptors
03/21/2001EP1083888A1 MULTIBINDING AGENTS THAT MODULATE PPARgamma AND RXR RECEPTORS
03/20/2001US6204001 Methods for determining compounds capable of inhibiting the activities of the Ha-Ras oncongene
03/14/2001EP1082289A1 Methods for identifying novel multimeric agents that modulate receptors
03/08/2001WO1999064047A8 Novel antiviral compounds
03/08/2001WO1999063930A8 Novel angiotensin receptor modulators and their uses
03/07/2001EP1080080A1 Novel therapeutic agents that modulate neurokinin receptors
03/07/2001CN1062909C Process for production of hydrolyzed vegetable proteins and product therefrom
03/01/2001WO2001014411A1 Recombinant subunit vaccine
03/01/2001WO2000065060A3 Dna sequence and recombinant production of a graminae allergen
03/01/2001CA2382176A1 Recombinant subunit vaccine
02/2001
02/28/2001EP0672142B1 Multivalent and multispecific binding proteins, their manufacture and use
02/27/2001US6194543 Dendritic polypeptides
02/22/2001WO1999063996A8 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors
02/20/2001CA2232878C Liquid detergents with ortho-substituted phenylboronic acids for inhibition of proteolytic enzymes
02/15/2001WO2000069900A3 Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
02/07/2001EP1073669A2 Gcp
02/01/2001WO2000058405A3 Squaraine dyes
01/2001
01/24/2001EP1070254A1 Compositions and methods for detecting ligand-dependent nuclear receptor and coactivator interactions
01/18/2001WO2001004316A2 Antigenic meningococcal peptides
01/18/2001WO1999064049A9 Novel antibacterial agents
01/18/2001CA2801979A1 Antigenic meningococcal peptides
01/17/2001EP1068524A1 Corticotropin releasing factor receptor 1-deficient mice
01/16/2001CA2010800C Protein labelling
01/10/2001EP1067136A1 New peptide derivatives
01/03/2001EP1064088A1 Fabrication of multilayer-coated particles and hollow shells via electrostatic self-assembly of nanocomposite multilayers on decomposable colloidal templates
01/03/2001CN1278530A Novel peptide derivative
12/2000
12/14/2000WO2000074701A2 Method and composition for inhibiting cardiovascular cell proliferation
12/14/2000WO2000053749A3 Vascular adhesion molecules and modulation of their function
11/2000
11/30/2000WO2000040700A3 Oocyte activation by sperm components
11/29/2000EP1055126A1 Methods and compositions for diagnosis of hepatoma
11/28/2000US6153589 2,3-epoxy alcohols, acids and derivatives as anti retroviral chemotherapeutic agents
11/23/2000WO2000069900A2 Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
11/23/2000CA2623458A1 Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
11/23/2000CA2505617A1 Modified secretin and method of synthesizing thereof
11/23/2000CA2499211A1 Modified peptides yy and conjugates thereof
11/14/2000US6147275 Corticotropin releasing factor receptor 1-deficient mice
11/02/2000WO2000065060A2 Dna sequence and recombinant production of a graminae allergen
10/2000
10/26/2000DE19918682A1 New recombinant DNA encoding an allergen produced by grasses of the Poaceae family, useful for diagnosis of pollen allergy and for treatment by desensitization
10/24/2000US6136599 Human hybrid host cell for mammalian gene expression
10/19/2000WO2000061813A1 A second mammalian tankyrase
10/19/2000CA2360318A1 A second mammalian tankyrase
1 ... 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48